sameAs
Viral kinetic modeling: state of the artAn immunology primer for computational modelersIntegrated PK-PD and agent-based modeling in oncologyIn vitro characterization of the erythrocyte distribution of methazolamide: a model of erythrocyte transport and binding kineticsHalf-life of diphenylpyraline in manEstimation of population characteristics of pharmacokinetic parameters from routine clinical dataComputation of the explicit solution to the Michaelis-Menten equationReceptor-mediated model relating anticonvulsant effect to brain levels of camazepam in the presence of its active metabolitesPharmacokinetics of phenylethylacetylurea (pheneturide), an old antiepileptic drugA kinetic-dynamic model to explain the relationship between high potency and slow onset time for neuromuscular blocking drugsThe deterministic identifiability of nonlinear pharmacokinetic models.On the identification of Michaelis-Menten elimination parameters from a single dose-response curve.A new statistical procedure for testing equivalence in two-group comparative bioavailability trials.A comparison of the Two One-Sided Tests Procedure and the Power Approach for assessing the equivalence of average bioavailabilityEmpirical models for fitting of oral concentration time curves with and without an intravenous reference.Exponential tails of drug disposition curves: reality or appearance?Circulatory model of vascular and interstitial distribution kinetics of rocuronium: a population analysis in patients.Nonlinear pharmacokinetics of therapeutic proteins resulting from receptor mediated endocytosisApplication of a single-objective, hybrid genetic algorithm approach to pharmacokinetic model buildingLinear pharmacokinetic equations allowing direct calculation of many needed pharmacokinetic parameters from the coefficients and exponents of polyexponential equations which have been fitted to the data.Pharmacokinetic analysis of drug concentration data obtained during repetitive drug administration.Modeling of Functional Assessment Questionnaire (FAQ) as continuous bounded data from the ADNI database.Identification of the primary mechanism of action of an insulin secretagogue from meal test data in healthy volunteers based on an integrated glucose-insulin model.Introduction to the analysis of PET data in oncology.Application of NONMEM to routine bioavailability data.Mixed-effects beta regression for modeling continuous bounded outcome scores using NONMEM when data are not on the boundaries.Modeling of PET data in CNS drug discovery and development.Is mixed effects modeling or naïve pooled data analysis preferred for the interpretation of single sample per subject toxicokinetic data?Considerations for the prediction of survival time in pancreatic cancer based on registry data.Selecting reliable pharmacokinetic data for explanatory analyses of clinical trials in the presence of possible noncompliance.The need for mixed-effects modeling with population dichotomous data.Analysis of toxicokinetic data using NONMEM: impact of quantification limit and replacement strategies for censored data.Ways to fit a PK model with some data below the quantification limit.Determination of an optimal dosage regimen using a Bayesian decision analysis of efficacy and adverse effect data.Use of prior information to stabilize a population data analysis.A joint model for nonlinear longitudinal data with informative dropout.Evaluation of Bayesian estimation in comparison to NONMEM for population pharmacokinetic data analysis: application to pefloxacin in intensive care unit patients.Evaluation of mixture modeling with count data using NONMEM.A two-part mixture model for longitudinal adverse event severity data.Simultaneous vs. sequential analysis for population PK/PD data I: best-case performance.
P1433
Q26824655-108058CD-CB5C-439F-9BED-D03DC4C0C204Q26852827-9067DB21-9BD8-4219-AFC3-599018C2E2F7Q27006577-1804E59D-D264-4E63-944D-1AFAB1D07451Q28146046-2F3AD727-006A-4700-BFCD-4929091810DBQ28237328-8F2741E5-476B-4B26-9E87-EBB28236EF0FQ28246268-A0991EB2-55A3-4F51-87AD-78FBDB83FCAEQ28272044-BFD5EA61-1B41-4967-85B8-FB5582656F6EQ28282681-BDB1D36C-06CB-4A81-8423-847C72FCCADBQ28328936-7703C62F-F919-4238-A228-1739DE4DBDE0Q29308428-F199A347-C07B-4CF3-830F-A1ED0E764B6BQ30011316-78339163-7605-4E54-9E5B-75996709A5BEQ30011319-BAE49DA9-30BA-41A8-B426-7FA548DD2ED8Q30062765-C82EB00F-B413-4536-A3EF-2A990C992D47Q30062775-013639B0-4FB4-4568-89B4-77CBD85B3CFCQ30313492-DCFF0B4A-8C94-45FB-88D4-E28C0651B6BFQ30317631-FFACF346-7FF1-444A-B49D-1D0AEB87B29EQ30318525-03416746-3EAD-4ECF-A6FC-4542ED815FDEQ30489162-BF9E4808-0D03-4EC0-B4FD-D4285E7584F8Q30521370-309EABB4-15F0-4FC5-88BD-D5004E0B30EBQ30558717-CA2B5023-5AE3-4413-9776-A71B4B8F1E01Q30561375-DA7A2C69-25CF-4CFB-AD2C-01228CE26E55Q30567951-DCD9501F-F419-4614-8157-590FDE920B97Q30578482-6F6B9967-5FB1-409F-BF50-21DE7403F6C5Q30594766-3FDD1457-80EA-4659-B17D-1FCC63F4740EQ30597644-5076BD99-D4B1-44FE-9589-F19A858C2916Q30621152-1CBD9508-C4B3-472A-A42D-9529A1E84E02Q30623699-D59BDC60-211F-4868-B117-44A84D74EE97Q30653113-8788A981-4068-49CD-9BBA-457DE56EA826Q30654731-84EC23B7-A952-4E42-9E99-7D79FB9F0AD5Q30664311-89A889A4-79F7-49E7-B25A-94AF89F06BFFQ30664314-A718CED0-05A2-41DE-B6B2-243CF74D7199Q30668533-1EEF7DEB-106D-49CB-B791-CC6FA182633EQ30668538-E82A106F-09D8-4FE1-A99E-C0D74610F104Q30716535-5B24C378-904E-4EA8-9ABD-0AE60806563DQ30801674-8CA35582-FA6A-470D-9A5E-C6500DABCB76Q30802185-65290BE9-A694-43ED-A6B3-B56E4B2B7D20Q30827141-AB7A0EE1-C760-4CEC-8BE2-DE91153F96D4Q30882655-BF6255D9-E9F6-46EF-AC8D-B72D7B48EBB0Q30907641-81AB4BE7-E81F-42C4-B9F6-1F9F9CE4C46FQ30909826-06E8523C-7B32-472C-B0F3-AAFA4029EB63
P1433
description
journal
@en
revista científica
@es
rivista scientifica
@it
wetenschappelijk tijdschrift van Springer Science+Business Media
@nl
wissenschaftliche Fachzeitschrift
@de
مجلة
@ar
name
Journal of Pharmacokinetics and Pharmacodynamics
@ast
Journal of Pharmacokinetics and Pharmacodynamics
@da
Journal of Pharmacokinetics and Pharmacodynamics
@de
Journal of Pharmacokinetics and Pharmacodynamics
@en
Journal of Pharmacokinetics and Pharmacodynamics
@es
Journal of Pharmacokinetics and Pharmacodynamics
@fi
Journal of Pharmacokinetics and Pharmacodynamics
@fr
Journal of Pharmacokinetics and Pharmacodynamics
@it
Journal of Pharmacokinetics and Pharmacodynamics
@nb
Journal of Pharmacokinetics and Pharmacodynamics
@nl
type
label
Journal of Pharmacokinetics and Pharmacodynamics
@ast
Journal of Pharmacokinetics and Pharmacodynamics
@da
Journal of Pharmacokinetics and Pharmacodynamics
@de
Journal of Pharmacokinetics and Pharmacodynamics
@en
Journal of Pharmacokinetics and Pharmacodynamics
@es
Journal of Pharmacokinetics and Pharmacodynamics
@fi
Journal of Pharmacokinetics and Pharmacodynamics
@fr
Journal of Pharmacokinetics and Pharmacodynamics
@it
Journal of Pharmacokinetics and Pharmacodynamics
@nb
Journal of Pharmacokinetics and Pharmacodynamics
@nl
altLabel
J. Pharmacokinet. Pharmacodyn
@de
prefLabel
Journal of Pharmacokinetics and Pharmacodynamics
@ast
Journal of Pharmacokinetics and Pharmacodynamics
@da
Journal of Pharmacokinetics and Pharmacodynamics
@de
Journal of Pharmacokinetics and Pharmacodynamics
@en
Journal of Pharmacokinetics and Pharmacodynamics
@es
Journal of Pharmacokinetics and Pharmacodynamics
@fi
Journal of Pharmacokinetics and Pharmacodynamics
@fr
Journal of Pharmacokinetics and Pharmacodynamics
@it
Journal of Pharmacokinetics and Pharmacodynamics
@nb
Journal of Pharmacokinetics and Pharmacodynamics
@nl
P236
P6981
P1055
P1058
P1476
Journal of Pharmacokinetics and Pharmacodynamics
@en